Status:
COMPLETED
Loreline Study: Characterization of Long Responders Under Eribuline
Lead Sponsor:
Centre Jean Perrin
Conditions:
Breast Cancer Patients
Therapy Related Tumor
Eligibility:
FEMALE
18-75 years
Brief Summary
There is currently no strict recommendations for the management of patients who have received at least one or two lines of anthracyclines-based chemotherapy and taxane therapy for advanced breast canc...
Detailed Description
The investigators will perform a cross-sectional study in patients with metastatic breast cancer who have failed treatment after the first line and beyond. In this study, the investigators will be pa...
Eligibility Criteria
Inclusion
- Women aged between 18 and 75 years
- Metastatic breast cancer patient
- Patients treated by Halaven® in second, third or fourth line of treatment for their metastatic breast cancer
- Halaven® treatment must have been received between September 2011 and December 2016
- Patients responding or in stability during at least 6 months under Halaven® treatment
- Patients pretreated by at least one line of any other chemotherapy
- Non opposition form dated and signed by the investigator (attesting that the patient consented orally that clinical, biological and imaging data concerning her were analyzed in this study)
Exclusion
- Male
- Patient with cognitive and psychiatric disorders
- Patient deprived of liberty by judicial or administrative decision
- Insufficient knowledge or understanding of the French language which does not allow for the non-opposition form to be understood
Key Trial Info
Start Date :
August 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT03771183
Start Date
August 23 2019
End Date
February 28 2021
Last Update
April 5 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Jean Minoz
Besançon, France, 25030
2
Centre Jean Perrin
Clermont-Ferrand, France, 63011
3
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, France, 42270
4
Centre Paul Strauss
Strasbourg, France, 67065